Hong Kong vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Tajikistan
100.0%
in 2024
Hong Kong rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Tajikistan
How they compare
Hong Kong currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 1 time across 13 shared years of data; in 2007 it was Hong Kong ahead.
Hong Kong ranks 1st and Tajikistan ranks 1st of 144 countries.
Across the 3 decades both report, Hong Kong averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Hong Kong | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.7% | 36.0% | 5.7% | Hong Kong |
| 2010s | 35.4% | 70.4% | 35.0% | Tajikistan |
| 2020s | 92.2% | 97.8% | 5.6% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Tajikistan?
- Hong Kong, at 100.0% against 100.0% in Tajikistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Tajikistan?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Tajikistan?
- 13 years are reported by both, from 2007 to 2024.
- How do Hong Kong and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.